Navigation Links
Graves' & Thyroid Disease National Patient Conference Set for San Diego, CA
Date:9/15/2008

BUFFALO, N.Y., Sept. 15 /PRNewswire-USNewswire/ -- Nancy Patterson Ph.D., Chair of the Graves' Disease Foundation announced it will hold its 2008 national Patient & Family Conference on October 17-19 at the Sheraton Resort in Carlsbad, California. The meeting is open to all patients and family members with Graves' disease or other thyroid gland disorders.

The leading cause of hyperthyroidism, Graves' disease represents a basic defect in the immune system, causing production of immunoglobulins (antibodies), which stimulate and attack the thyroid gland, causing growth of the gland and overproduction of thyroid hormone. Similar antibodies may also attack the tissues in the eye muscles and in the pretibial skin (the skin on the front of the lower leg). Graves' Disease affects two out of every 100 women but less common in men.

The Conference will focus on Graves' disease symptoms & treatment, hypothyroidism & hyperthyroidism, thyroid-related eye conditions; and an update on the latest Graves' disease research. Also workshops on the emotional and psychological impact of Graves' disease. You'll meet other patients coping with Graves' and thyroid-related illnesses.

Dr. Terry Smith, who is Chief Medical & Scientific Officer of the Graves' Disease Foundation and Professor of Medicine, at Harbor-UCLA Medical Center & The David Geffen School of Medicine at UCLA; is Conference Chair for this year's meeting.

Dr. Smith announced the following keynote physicians and renowned experts will speak at the Conference:

Raymond Douglas, MD

Jules Stein Eye Institute

Michael Kazim, MD

Columbia University, NY

Don O. Kikkawa, MD

Shiley Eye Center, La Jolla, CA.

Ira Lesser, MD

Harbor-UCLA Medical Ctr.

Some thyroid topics will be:

-- The Scientific basis for Graves' disease: how little we really know!

-- Medical & surgical approaches to hyperthyroidism

-- Modern approaches to double vision in Graves' ophthalmology

-- Bony decompression for Graves' opthalmopathy

-- The emotional impact of Graves' disease on patients and their families

-- The role of Steroids & Radiotherapy in Graves' opthalmopathy

-- New therapeutic approaches for Graves' disease on the horizon

For more Conference details, call the Graves' Disease Foundation's toll-free 1 (877) NGDF-123, or its website: http://www.NGDF.org.

Receive a free Graves' disease pamphlet or newsletter, send an email to: GravesEnewsletter@verizon.net.


'/>"/>
SOURCE Graves' Disease Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
2. Fluoride Damages the Thyroid, Report Shows
3. Thyroid Test Wont Help Pregnant Mom, Baby
4. Better detection accounts for increase in cases of thyroid cancer
5. Thyroid treatment no quick fix for weight loss in children
6. Early detection critical in treating pediatric thyroid cancer
7. Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl
8. Combination of Thyroid Medicines Not Necessary
9. Newly discovered role of thyroid hormone during pregnancy
10. Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease?
11. Thyroid Hormone Could One Day Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: